I never could have imagined that exactly 28 years after being diagnosed with Multiple Sclerosis, I’d find myself on a runway in Fort Lauderdale, Florida—modeling adaptive clothing, no less. And I certainly never imagined I’d be modeling adaptive clothing with my husband. But that’s exactly…
Disability progression is not always permanent for people with relapsing-remitting multiple sclerosis (RRMS), even when it occurs independent of a relapse, a new study has found. Researchers report that nearly one-third of RRMS patients who experience progression independent of relapse activity (PIRA) see their disability…
Tweet Patient and public involvement (PPI) has been the mantra in grant review and research funding for years. It is said that “People living with a health condition are often in a better position to know what questions remain unanswered about their treatment or condition,…
“Don’t thank me yet.” Whenever I use that phrase, I mean it in the way it’s traditionally meant. Whatever it is that you’re thanking me for isn’t complete, so wait until I’m done in case you’re not entirely thankful for the results. That’s how I’ve…
Tweet De Meo E, Addazio I, Portaccio E, Bonacchi R, Betti M, Patti F, Guerrieri S, Foschi M, Ferraro D, Annovazzi P, Brescia Morra V, Tortorella C, Lugaresi A, Camilli F, Pozzilli C, Perini P, Granella F, De Luca G, Torri Clerici VLAM, Vianello M,…
The holidays tend to arrive with a mix of excitement and stress, even for people without a chronic illness. But for those of us living with multiple sclerosis (MS), the season can feel like its own kind of marathon, full of expectations, overscheduling, symptoms that…
Oligodendrocytes, the cells that build and repair myelin in the brain and spinal cord, may play a role in the inflammatory processes involved in multiple sclerosis (MS), even at the earliest stages of disease, according to a study in a mouse model. “We found that…
More than 3 million doses of Vueway (gadopiclenol), a lower-dose gadolinium contrast MRI agent used to diagnose and monitor conditions such as multiple sclerosis (MS), have been administered at more than 900 customer sites, maker Bracco Diagnostics said. Approved by the U.S. Food and Drug Administration for…
The post From our CEO appeared first on MS Australia. Source: www.msaustralia.org.au
